Aug 8 |
Zepbound shortages ease, but Lilly cautions pharmacy availability may remain ‘choppy’
|
Aug 8 |
Excitement grows around Eli Lilly's GLP-1 drugs in Q2 earnings
|
Aug 8 |
Stocks to Watch Thursday: Warner Bros, Bumble, Zillow, Eli Lilly
|
Aug 8 |
Eli Lilly (LLY) Q2 Earnings Top, Mounjaro, Zepbound Drive View
|
Aug 8 |
Continuing Claims Hit Highest Since Nov 2021
|
Aug 8 |
Biggest stock movers today: UAA, WBD, MNST, and more
|
Aug 8 |
Eli Lilly stock jumps on GLP-1 sales, end of manufacturing shortage
|
Aug 8 |
Eli Lilly stock surges on Q2 earnings beat, revenue outlook
|
Aug 8 |
Compared to Estimates, Lilly (LLY) Q2 Earnings: A Look at Key Metrics
|
Aug 8 |
Eli Lilly in charts: Mounjaro, Zepbound, Verzenio, and Jardiance power Q2 performance
|